⌘K

Login Start Free

Home/Filings/4/0001739410-25-000013

4//SEC Filing

Ryder Steven 4

Accession 0001739410-25-000013

CIK 0001739410other

View on SEC.gov Company Profile

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 7:29 PM ET

Size

5.4 KB

Accession

0001739410-25-000013

Insider Transaction Report

Form 4

Period: 2025-02-14

Rallybio CorpRLYB

Chief Medical Officer

Transactions

Award
Option (Right to Buy)
2025-02-14+180,000→ 180,000 total
Exercise: $0.76Exp: 2035-02-14→ Common Stock (180,000 underlying)

Footnotes (1)

[F1]The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in 48 equal monthly installments until fully vested on February 14, 2029.

Documents

1 file

4
wk-form4_1740011340.xmlPrimary
FORM 4

Issuer

Rallybio Corp

CIK 0001739410

Entity typeother

Related Parties

1

filerCIK 0001872868

Filing Metadata

Form type: 4
Filed: Feb 18, 7:00 PM ET
Accepted: Feb 19, 7:29 PM ET
Size: 5.4 KB

View on SEC.gov